OAM
CRMD icon

Oberweis Asset Management’s CorMedix CRMD Stock Holding History

Oberweis Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
1,323,915
+112,800
+9% +$891K 0.21% 129
2026
Q1 		$8.22M Buy
1,211,115
+406,000
+50% +$3M 0.24% 124
2025
Q4 		$9.36M Buy
805,115
+19,415
+2% +$215K 0.34% 109
2025
Q3 		$9.14M Buy
785,700
+300,700
+62% +$3.64M 0.35% 108
2025
Q2 		$5.98M Hold
485,000
– – 0.26% 131
2025
Q1 		$2.99M Buy
+485,000
New +$5.02M 0.15% 156

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Oberweis Asset Management's CRMD Position: Q2 2026 in Review

Oberweis Asset Management increased its CorMedix (CRMD) stake by 9.3% in Q2 2026, buying an estimated $891K and bringing the position to 1,323,915 shares worth $10.4M. The position accounts for 0.21% of the portfolio, ranked #129.

Oberweis Asset Management first reported a position in CRMD in Q1 2025 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Oberweis Asset Management held 1,323,915 shares of CorMedix worth $10.4M as of Q2 2026.
  • Oberweis Asset Management bought 112,800 CorMedix shares in Q2 2026, an estimated $891K.
  • CorMedix made up 0.21% of Oberweis Asset Management's portfolio in Q2 2026, its #129 holding.
  • Oberweis Asset Management first reported a position in CorMedix in Q1 2025 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.